RHS's Pending Acquisition

RHS raised a round of funding on February 26, 2018. Investors include PerkinElmer.

RHS Ltd was founded to develop advanced patented single cell genomic technologies. Since its inception, RHS has maintained focus on improving health and research outcomes and has built a team and know…

Articles about RHS's Pending Acquisition: